Biomerica (BMRA) Total Current Liabilities (2011 - 2026)

Biomerica has disclosed Total Current Liabilities across 16 years of filings, most recently posting $1.6 million for Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $1.6 million, down 5.34% year-over-year; the trailing twelve-month figure through Feb 2026 was $1.6 million (down 5.34% YoY), and the FY2025 annual result was $1.7 million, down 21.05% from the prior year.
• Total Current Liabilities came in at $1.6 million for Q1 2026 at Biomerica, down from $1.6 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $6.7 million in Q1 2022 to a low of $1.4 million in Q1 2023.
• The 5-year median for Total Current Liabilities is $1.8 million (2022), against an average of $2.1 million.
• Across the five-year window, Total Current Liabilities jumped 395.41% in 2022 and slumped 79.17% in 2023, its largest moves.
• Biomerica's Total Current Liabilities stood at $1.8 million in 2022, then gained by 3.33% to $1.8 million in 2023, then grew by 2.96% to $1.9 million in 2024, then fell by 14.77% to $1.6 million in 2025, then slipped by 2.38% to $1.6 million in 2026.
• The last three Total Current Liabilities figures came in at $1.6 million (Q1 2026), $1.6 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.